Przejdź do zawartości
Merck
  • Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains.

Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains.

Molecular biology of the cell (2010-01-22)
Himabindu Penmatsa, Weiqiang Zhang, Sunitha Yarlagadda, Chunying Li, Veronica G Conoley, Junming Yue, Suleiman W Bahouth, Randal K Buddington, Guangping Zhang, Deborah J Nelson, Monal D Sonecha, Vincent Manganiello, Jeffrey J Wine, Anjaparavanda P Naren
ABSTRAKT

Formation of multiple-protein macromolecular complexes at specialized subcellular microdomains increases the specificity and efficiency of signaling in cells. In this study, we demonstrate that phosphodiesterase type 3A (PDE3A) physically and functionally interacts with cystic fibrosis transmembrane conductance regulator (CFTR) channel. PDE3A inhibition generates compartmentalized cyclic adenosine 3',5'-monophosphate (cAMP), which further clusters PDE3A and CFTR into microdomains at the plasma membrane and potentiates CFTR channel function. Actin skeleton disruption reduces PDE3A-CFTR interaction and segregates PDE3A from its interacting partners, thus compromising the integrity of the CFTR-PDE3A-containing macromolecular complex. Consequently, compartmentalized cAMP signaling is lost. PDE3A inhibition no longer activates CFTR channel function in a compartmentalized manner. The physiological relevance of PDE3A-CFTR interaction was investigated using pig trachea submucosal gland secretion model. Our data show that PDE3A inhibition augments CFTR-dependent submucosal gland secretion and actin skeleton disruption decreases secretion.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Anti-CFTR Antibody, a.a. 1370-1380, clone M3A7, clone M3A7, Chemicon®, from mouse